Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellebrite DI Ltd. covers the month of July 2023, with a report date of July 10, 2023. The document serves to announce the results of the Company's Annual General Meeting of Shareholders held on July 6, 2023.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters regarding the shareholder meeting.
Material Changes
There are no material financial changes reported in this document. The primary event is the successful approval of all shareholder proposals presented at the Annual General Meeting.
Guidance, Outlook, and Management Commentary
Management commentary is limited to the confirmation that all proposals were approved by the requisite majority under Israeli Companies Law. No financial guidance, outlook, risks, or contingencies are detailed in this specific filing.
Key Facts for Investor Verification
- All proposals brought before the Annual General Meeting on July 6, 2023, were approved by shareholders.
- 166,484,525 ordinary shares were present or represented by proxy at the meeting.
- Attendance represented approximately 84.96% of the issued and outstanding ordinary shares as of the record date.
- This report is incorporated by reference into the Company's registration statements on Form S-8 and Form F-3.